Showing results (1951-1960 of 2,059) with videos related to

Sort By:
Pageof 206
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2025
Understanding the role of NOTCH2 mutation in centronuclear myopathyYouxi Lin, Hang Zhou, Wenjun Hu, et al.
ACS Applied Materials & Interfaces|March 21, 2022
Smart, Biomimetic Periosteum Created from the Cerium(III, IV) Oxide-Mineralized Eggshell MembraneQian-Qian Wan, Kai Jiao, Yu-Xuan Ma, et al.
Cell Research|May 4, 2011
Indian hedgehog mutations causing brachydactyly type A1 impair Hedgehog signal transduction at multiple levelsGang Ma, Jiang Yu, Yue Xiao, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 16, 2021
Feasibility and safety of both His bundle pacing and left bundle branch area pacing in atrial fibrillation patients: intermediate term follow-upYang Ye, Kai Zhang, Ying Yang, et al.
Translational Psychiatry|November 21, 2025
Deciphering the molecular tapestry of schizophrenia: integrating transcriptomics, neuroimaging, and clinical data for precision medicineJia-Ni Zhao, Yun-Qi Wang, Min Liu, et al.
Journal of Medical Virology|January 18, 2024
Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosisShanghao Liu, Jianzhong Ma, Ping Chen, et al.
Nature Medicine|March 1, 2024
A gut microbial signature for combination immune checkpoint blockade across cancer typesAshray Gunjur, Yan Shao, Timothy Rozday, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2021
Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitorsJia Liu, Malinda Itchins, Adnan Nagrial, et al.
EMBO Molecular Medicine|February 20, 2019
MET mutation causes muscular dysplasia and arthrogryposisHang Zhou, Chengjie Lian, Tingting Wang, et al.
Journal for Immunotherapy of Cancer|February 22, 2023
SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancerJun Zhao, Xinmin Yu, Dingzhi Huang, et al.
Pageof 206